Blood bank reagents
Ended Awarded Last action
- Contract number
- 36C25719N0518
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $50,427
Award facts
- Contract value 62% obligated
-
- $50,427.46 Current, with exercised options
- $81,733.18 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Newtown, PA 18940, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$1,544 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$757 | |
| Exercise an Option | $17,455 | |
| Exercise an Option | $17,819 | |
| Original award | $17,455 |
About this award
This federal contract award to Alba Bioscience, Inc. is for the delivery of blood bank reagents, including products such as ALBACYTE antibody screening cells, ALBACLONE antibodies, ALBAHANCE additives, and ALBASURE quality control kits. The contract has a ceiling value of $81,733.18 and a period of performance from April 1, 2019 to April 1, 2020.
Alba Bioscience, Inc. is a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and related medical supplies to federal agencies, particularly the Department of Veterans Affairs (VA), Defense Logistics Agency (DLA), and Department of Health and Human Services (HHS). The company holds two significant Blanket Purchase Agreements (BPAs) with the VA, valued at $109,420.35 and $30,000, for the supply of red blood cell reagents and blood bank reagents, respectively. These contracts support the VA's healthcare operations by ensuring a reliable supply of critical blood banking products. This specific award does not have a set-aside designation, reflecting the specialized nature of the medical products being provided.
Quick answers
Who was awarded contract 36C25719N0518?
36C25719N0518 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on April 1, 2019.
How much is contract 36C25719N0518 worth?
The government has obligated $50,427 on 36C25719N0518. Its potential value, with all options, is $81,733.
Is contract 36C25719N0518 an order under another contract?
Yes. 36C25719N0518 is a delivery order under V797P2050D, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25719N0518 competed?
The extent of competition for 36C25719N0518 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award